Franz X. Vollenweider
TitleCited byYear
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
FX Vollenweider, MFI Vollenweider-Scherpenhuyzen, A Bäbler, H Vogel, ...
Neuroreport 9 (17), 3897-3902, 1998
5491998
Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia
D Umbricht, L Schmid, R Koller, FX Vollenweider, D Hell, DC Javitt
Archives of general psychiatry 57 (12), 1139-1147, 2000
5452000
Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naıve healthy volunteers
FX Vollenweider, A Gamma, M Liechti, T Huber
Neuropsychopharmacology 19 (4), 241-251, 1998
4801998
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
FX Vollenweider, M Kometer
Nature Reviews Neuroscience 11 (9), 642, 2010
3602010
Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F] fluorodeoxyglucose (FDG)
FX Vollenweider, KL Leenders, C Scharfetter, A Antonini, P Maguire, ...
European neuropsychopharmacology 7 (1), 9-24, 1997
3491997
Gender differences in the subjective effects of MDMA
ME Liechti, A Gamma, FX Vollenweider
Psychopharmacology 154 (2), 161-168, 2001
3412001
Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis
FX Vollenweider, KL Leenders, C Scharfetter, P Maguire, O Stadelmann, ...
Neuropsychopharmacology 16 (5), 357-372, 1997
3301997
Serotonin research: contributions to understanding psychoses
MA Geyer, FX Vollenweider
Trends in pharmacological sciences 29 (9), 445-453, 2008
3172008
Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission …
FX Vollenweider, KL Leenders, I Øye, D Hell, J Angst
European Neuropsychopharmacology 7 (1), 25-38, 1997
2961997
Acute psychological effects of 3, 4-methylenedioxymethamphetamine (MDMA,“Ecstasy”) are attenuated by the serotonin uptake inhibitor citalopram
ME Liechti, C Baumann, A Gamma, FX Vollenweider
Neuropsychopharmacology 22 (5), 513, 2000
2722000
A systems model of altered consciousness: integrating natural and drug-induced psychoses
FX Vollenweider, MA Geyer
Brain research bulletin 56 (5), 495-507, 2001
2612001
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study
F Hasler, U Grimberg, MA Benz, T Huber, FX Vollenweider
Psychopharmacology 172 (2), 145-156, 2004
2292004
Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia
K Ludewig, MA Geyer, FX Vollenweider
Biological psychiatry 54 (2), 121-128, 2003
2292003
Effects of (S)-ketamine on striatal dopamine: a [11C] raclopride PET study of a model psychosis in humans
FX Vollenweider, P Vontobel, I Øye, D Hell, KL Leenders
Journal of psychiatric research 34 (1), 35-43, 2000
2292000
Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans
ME Liechti, MR Saur, A Gamma, D Hell, FX Vollenweider
Neuropsychopharmacology 23 (4), 396, 2000
2242000
The responsiveness of the Hamilton depression rating scale
D Faries, J Herrera, J Rayamajhi, D DeBrota, M Demitrack, WZ Potter
Journal of psychiatric research 34 (1), 3-10, 2000
2162000
Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers
D Umbricht, R Koller, FX Vollenweider, L Schmid
Biological psychiatry 51 (5), 400-406, 2002
2052002
5-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [11C]raclopride
FX Vollenweider, P Vontobel, D Hell, KL Leenders
Neuropsychopharmacology 20 (5), 424, 1999
2041999
Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies
ME Liechti, FX Vollenweider
Human Psychopharmacology: Clinical and Experimental 16 (8), 589-598, 2001
1982001
Psychometric evaluation of the altered states of consciousness rating scale (OAV)
E Studerus, A Gamma, FX Vollenweider
PloS one 5 (8), e12412, 2010
1932010
The system can't perform the operation now. Try again later.
Articles 1–20